Switch theme
Sign up to access all valuation multiples
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
1990
19
LTM Revenue $9.7M
LTM EBITDA -$3.4M
$38.1M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Integrum has a last 12-month revenue (LTM) of $9.7M and a last 12-month EBITDA of -$3.4M.
In the most recent fiscal year, Integrum achieved revenue of $10.7M and an EBITDA of $0.9M.
Integrum expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Integrum valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $9.7M | XXX | $10.7M | XXX | XXX | XXX |
| Gross Profit | $7.8M | XXX | $9.4M | XXX | XXX | XXX |
| Gross Margin | 80% | XXX | 88% | XXX | XXX | XXX |
| EBITDA | -$3.4M | XXX | $0.9M | XXX | XXX | XXX |
| EBITDA Margin | -35% | XXX | 8% | XXX | XXX | XXX |
| EBIT | -$3.8M | XXX | $0.1M | XXX | XXX | XXX |
| EBIT Margin | -39% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | -$3.0M | XXX | $0.4M | XXX | XXX | XXX |
| Net Margin | -31% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Integrum's stock price is SEK 18 (or $2).
Integrum has current market cap of SEK 379M (or $39.1M), and EV of SEK 369M (or $38.1M).
See Integrum trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $38.1M | $39.1M | XXX | XXX | XXX | XXX | $-0.13 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Integrum has market cap of $39.1M and EV of $38.1M.
Integrum's trades at 3.9x EV/Revenue multiple, and -17.8x EV/EBITDA.
Equity research analysts estimate Integrum's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Integrum has a P/E ratio of -12.8x.
See valuation multiples for Integrum and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $39.1M | XXX | $39.1M | XXX | XXX | XXX |
| EV (current) | $38.1M | XXX | $38.1M | XXX | XXX | XXX |
| EV/Revenue | 3.9x | XXX | 3.9x | XXX | XXX | XXX |
| EV/EBITDA | -11.2x | XXX | -17.8x | XXX | XXX | XXX |
| EV/EBIT | -10.1x | XXX | -14.3x | XXX | XXX | XXX |
| EV/Gross Profit | 4.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | -12.8x | XXX | -19.3x | XXX | XXX | XXX |
| EV/FCF | -9.7x | XXX | -10.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialIntegrum's last 12 month revenue growth is 49%
Integrum's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.5M for the same period.
Integrum's rule of 40 is 48% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Integrum's rule of X is 86% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Integrum and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 49% | XXX | 37% | XXX | XXX | XXX |
| EBITDA Margin | -35% | XXX | -22% | XXX | XXX | XXX |
| EBITDA Growth | -92% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 48% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 86% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 87% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Integrum acquired XXX companies to date.
Last acquisition by Integrum was XXXXXXXX, XXXXX XXXXX XXXXXX . Integrum acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Integrum founded? | Integrum was founded in 1990. |
| Where is Integrum headquartered? | Integrum is headquartered in Sweden. |
| How many employees does Integrum have? | As of today, Integrum has 19 employees. |
| Is Integrum publicy listed? | Yes, Integrum is a public company listed on STO. |
| What is the stock symbol of Integrum? | Integrum trades under INTEG B ticker. |
| When did Integrum go public? | Integrum went public in 2017. |
| Who are competitors of Integrum? | Similar companies to Integrum include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Integrum? | Integrum's current market cap is $39.1M |
| What is the current revenue of Integrum? | Integrum's last 12 months revenue is $9.7M. |
| What is the current revenue growth of Integrum? | Integrum revenue growth (NTM/LTM) is 49%. |
| What is the current EV/Revenue multiple of Integrum? | Current revenue multiple of Integrum is 3.9x. |
| Is Integrum profitable? | Yes, Integrum is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Integrum? | Integrum's last 12 months EBITDA is -$3.4M. |
| What is Integrum's EBITDA margin? | Integrum's last 12 months EBITDA margin is -35%. |
| What is the current EV/EBITDA multiple of Integrum? | Current EBITDA multiple of Integrum is -11.2x. |
| What is the current FCF of Integrum? | Integrum's last 12 months FCF is -$3.9M. |
| What is Integrum's FCF margin? | Integrum's last 12 months FCF margin is -40%. |
| What is the current EV/FCF multiple of Integrum? | Current FCF multiple of Integrum is -9.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
